HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacPherson, C. F. C. Articles by Yo, S.-L. Search for Related Content PubMed Articles by MacPherson, C. F. C. Articles by Yo, S.-L.

Studies on Brain Antigens

VI. Prevention of Experimental Allergic Encephalomyelitis by a Qater-Soluble Spinal Cord Protein, ₁-SCP¹

From the Departments of Psychiatry and Biochemistry, McGill University, Montreal, Quebec

Abstract

Pretreatment of guinea pigs with a purified bovine spinal cord protein (₁-SCP) prevented them from developing experimental allergic encephalitis (EAE) when they were subsequently challenged with an excessive dose of bovine spinal cord in complete Freund's adjuvant. In contrast, guinea pigs treated with protein obtained from bovine liver or with protein extracted from the gray matter of bovine brain developed EAE similar in severity to the disease induced in animals which had not been pretreated. When used to challenge guinea pigs, ₁-SCP was not encephalitogenic at a level of 300 µg. This was the total amount of ₁-SCP used for the pretreatment of each animal. The protective activity of the ₁-SCP is assumed to be mediated by anti-SCP immunoglobulin but at this stage of our research the mechanism of the protective action is not clear. The protective action may not be directed specifically against lymphocytes sensitized to the encephalitogenic protein of myelin because anti-₁-SCP antibody did not react in immunodiffusion experiments with myelin isolated by differential centrifugation.

Footnotes

¹ This work was supported by the Multiple Sclerosis Society of Canada and the Medical Research Council of Canada.

² Present address: Departments of Psychiatry and Clinical Neurological Sciences, University Hospital, University of Western Ontario, London 72, Ontario.

This article has been cited by other articles:

				R. Auerbach and J. Roethle Tolerance to Heterologous Erythrocytes Science, January 25, 1974; 183(4122): 332 - 334. [Abstract] [PDF]